CE vs TRDA · rev $10.28B vs P/E 12, rev $210.8M
Celanese Corporation (CE) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
CE currently screens at market cap $5.92B. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the CE and TRDA stock pages for the full models.
Not investment advice.